United Therapeutics (UTHR) Asset Utilization Ratio (2010 - 2026)
United Therapeutics (UTHR) posted Asset Utilization Ratio of 0.43 for Q1 2026, up 3.94% sequentially from 0.42 in Q4 2025, and up 9.59% YoY from 0.4 in Q1 2025.
United Therapeutics (UTHR) Asset Utilization Ratio (2010 - 2026) Analysis & Trends
United Therapeutics has reported Asset Utilization Ratio for 17 years, with the latest figure at 0.43 in Q1 2026.
- Quarterly Asset Utilization Ratio rose 9.59% year-over-year to 0.43 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.43 (up 9.59% YoY) and the FY2025 annual result came in at 0.42, up 5.44% from the prior year.
- Asset Utilization Ratio advanced to 0.43 in Q1 2026 per UTHR's latest filing, from 0.42 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.82 in Q3 2024 and troughed at 0.32 in Q1 2023.
- A 5-year average of 0.41 and a median of 0.37 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2024 and 2025: Asset Utilization Ratio surged 154.78% in 2024, then plunged 49.97% in 2025.
- Over 5 years, Asset Utilization Ratio stood at 0.33 in 2022, then advanced by 0.17% to 0.33 in 2023, then surged by 138.15% to 0.78 in 2024, then tumbled by 46.5% to 0.42 in 2025, then grew by 3.94% to 0.43 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.43, 0.42, and 0.41 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.42 Bn | 39.76 Bn | 2.15 Bn | 0.43 |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | 0.63 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.98 Bn | 5.10 Bn | 0.47 |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 0.45 |
| 6 | Viatris | 18.78 Bn | 17.89 Bn | 1.46 Bn | 0.41 |
| 7 | Neurocrine Biosciences | 15.66 Bn | 15.27 Bn | 935.80 Mn | 0.66 |
| 8 | Elanco Animal Health | 11.91 Bn | 11.38 Bn | 798.00 Mn | 0.37 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Alkermes | 8.20 Bn | 7.55 Bn | 397.90 Mn | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.45 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.42 |
| Sep 30, 2025 | 0.41 |
| Jun 30, 2025 | 0.39 |
| Mar 31, 2025 | 0.40 |
| Dec 31, 2024 | 0.78 |
| Sep 30, 2024 | 0.82 |
| Jun 30, 2024 | 0.40 |
| Mar 31, 2024 | 0.37 |
| Dec 31, 2023 | 0.33 |
| Sep 30, 2023 | 0.32 |
| Jun 30, 2023 | 0.32 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.33 |
| Sep 30, 2022 | 0.33 |
| Jun 30, 2022 | 0.33 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.33 |
| Sep 30, 2021 | 0.33 |